Editas Medicine
EDIT
194 hedge funds and large institutions have $780M invested in Editas Medicine in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 57 reducing their positions, and 36 closing their positions.
12% more call options, than puts
Call options by funds: $20.3M | Put options by funds: $18.2M
2.45% more ownership
Funds ownership: 69.66% → 72.11% (+2.4%)
8% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 36
9% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 57
3% less funds holding
Funds holding: 199 → 194 (-5)
26% less capital invested
Capital invested by funds: $1.06B → $780M (-$277M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
+$23.6M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$9.43M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$6.28M |
| 4 |
Goldman Sachs
New York
|
+$5.35M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$4.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$21M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.16M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.74M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.39M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$2.78M |
EDIT Hedge Fund Activity: Q4 2018 in Review
194 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2018, worth a combined $780M — down 26% from $1.06B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of EDIT and 33 opened new positions — a net loss of 3 holders — while 57 trimmed existing stakes and 52 added.
The largest buyer was Ontario Teachers' Pension Plan Board, opening a new position worth an estimated $23.6M. The largest seller was State Street, cutting an estimated $21M.
- 194 institutional investors held Editas Medicine (EDIT) as of Q4 2018, down from 199 in Q3 2018.
- Funds reported $780M of Editas Medicine stock for Q4 2018, down 26% quarter-over-quarter.
- 33 funds opened new Editas Medicine positions in Q4 2018 and 36 closed out, a net change of -3 holders.
- The largest Editas Medicine buyer in Q4 2018 was Ontario Teachers' Pension Plan Board, an estimated $23.6M added.
- The largest Editas Medicine seller in Q4 2018 was State Street, an estimated $21M sold.
Based on aggregated 13F filings for Q4 2018.